BioNTech and Pfizer raised this year’s production target for their Covid-19 vaccine to as many as 2.5 billion doses, with the German biotech’s chief executive predicting a version of the shot that can be stored in refrigerators will be ready within months. BioNTech said it expects €9.8 billion in revenue from the supply contracts signed already, which amount to 1.4 billion doses. BioNTech and Pfizer had previously said they could make about 2 billion pandemic shots this year, enough to immunise 1 billion people. Next year, the partners could have capacity to make 3 billion doses, Mr Sahin said. BioNTech reported €366.9 million in fourth-quarter profit, compared with a €58.2 million loss in the year-earlier quarter.

Source: The Irish Times March 30, 2021 12:08 UTC